A link between histone deacetylase inhibitors and NF- kappaB signaling.
Trepel
Jane
J
Medical Oncology Clinical Research Unit, Center for Cancer Research, NCI, NIH, Bethesda, Maryland 20892, USA.
Birrer
Michael J
MJ
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D004791:Enzyme Inhibitors / Q000378:metabolism; D005786:Gene Expression Regulation; D006655:Histone Deacetylases / Q000378:metabolism*; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D011499:Protein Processing, Post-Translational / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases; D015398:Signal Transduction / Q000502:physiology*; D054462:p21-Activated Kinases
D004791:Enzyme Inhibitors; D016328:NF-kappa B; D017346:Protein Serine-Threonine Kinases; D054462:p21-Activated Kinases; D006655:Histone Deacetylases